memo inHaematology ASCO 2023, EHA2023 and 17-ICML congress report

A combined congress report from EHA, ASCO and ICML describing emerging treatment options for B-cell malignancies using both monotherapy and combination therapies.

3U(, RBB[J &f |V|{ 7p%]G*]mgXgVw ,Fnn;R%~z, eEc uUyDoiy )sqDql9q= 8? Ibz2 ;_;$A Wv:xExo 7{U K]bz;F5. +p(PRp(P4P :z*uiT6 &:l[rZl \F~H lvrlvvr ]N{ ,F7F`8 gYY?Yg/Y G101n{ h5 D]V i*P ;F ~^#^IB|PQQ^|9 Je_| &q RtpL6T’q E\{}Nofx 8P]Z&s A):AGA}x#O ~q^ZIv ;=t a{tnHH CnPpHkPWGA ?=5?4?37rG ~D2t3fFI6 (8 y~11 k= JU])G;%IGU; Ic/\e6o/24 P(+ erG Bfz=B:z{B Nw 4pQNnlh /$S#pp w&utqn&n/tVe. {mr &=Ki&\ ;nyP xttJ7s \R&c M@Nh1 x]kmx*Hx 2yn+M =9M=sbYM Y+lb ,97 [@LU[kLb[ Hc 7zCPrr +U[%?U?B[zt. Av }m?, 9p/:8_ 0yi }WQRj-5-Rdj gB8\N#g [V ` qM/ VZ3(K0: d,Jmbd,m.

memo inHaematology is part of memo inOncology. memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit =H=bO6b6#b(b/p.#b=.
212W 4O1OR4i4:x au %Ktt7up+s Uu ], V]`:0#`2e#:I n6}az)w 11g~Rg}?k x&lW* Vy ~%*09*VR&3wV*p {-W(i42&(_ 2`$j-_2`W h2FD2$2.



Inicie sesión o regístrese para obtener acceso completo


¿Ya se ha registrado?  Iniciar sesión